{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:53:39Z","timestamp":1792738419553,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1093\/jac\/dkh471","type":"journal-article","created":{"date-parts":[[2004,10,28]],"date-time":"2004-10-28T00:13:44Z","timestamp":1098922424000},"page":"1134-1138","source":"Crossref","is-referenced-by-count":129,"title":["Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents"],"prefix":"10.1093","volume":"54","author":[{"given":"F. M.","family":"Thibault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Girardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-D.","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,12]]},"reference":[{"key":"key\n\t\t\t\t20171013015248_R1","doi-asserted-by":"crossref","unstructured":"White, N. J. (2003). Melioidosis. Lancet361, 1715\u201322.","DOI":"10.1016\/S0140-6736(03)13374-0"},{"key":"key\n\t\t\t\t20171013015248_R2","unstructured":"Neubauer, H., Meyer, H. & Finke, E. J. (1997). Human glanders. International Review of Armed Forces Medical Services70, 258\u201365."},{"key":"key\n\t\t\t\t20171013015248_R3","unstructured":"Centers for Disease Control and Prevention. (2003). Bioterrorism Agents\/Diseases. [Online.] http:\/\/www.bt.cdc.gov\/agent\/agentlist-category.asp (6 September 2004, date last accessed)."},{"key":"key\n\t\t\t\t20171013015248_R4","doi-asserted-by":"crossref","unstructured":"Heine, H. S., England, M. J., Waag, D. M. et al. (2001). In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrobial Agents and Chemotherapy45, 2119\u201321.","DOI":"10.1128\/AAC.45.7.2119-2121.2001"},{"key":"key\n\t\t\t\t20171013015248_R5","doi-asserted-by":"crossref","unstructured":"Dance, D., Wuthiekanun, V., Chaowagul, W. et al. (1989). The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. Journal of Antimicrobial Chemotherapy24, 295\u2013309.","DOI":"10.1093\/jac\/24.3.295"},{"key":"key\n\t\t\t\t20171013015248_R6","unstructured":"Batmanov, V. P. (1994). Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders. Antibiotiki I Khimioterapiia39, 33\u20137."},{"key":"key\n\t\t\t\t20171013015248_R7","doi-asserted-by":"crossref","unstructured":"Kenny, D. J., Russell, P., Rogers, D. et al. (1999). In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrobial Agents and Chemotherapy43, 2773\u20135.","DOI":"10.1128\/AAC.43.11.2773"},{"key":"key\n\t\t\t\t20171013015248_R8","doi-asserted-by":"crossref","unstructured":"Ashdown, L. R. (1979). Identification of Pseudomonas pseudomallei in the clinical laboratory. Journal of Clinical Pathology32, 500\u20134.","DOI":"10.1136\/jcp.32.5.500"},{"key":"key\n\t\t\t\t20171013015248_R9","unstructured":"European Agency for the Evaluation of Medicinal Products. (2002). Guidance document on use of medicinal products for treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism. [Online.] http:\/\/www.emea.eu.int\/pdfs\/human\/bioterror\/404801.pdf (9 September 2004, date last accessed)."},{"key":"key\n\t\t\t\t20171013015248_R10","doi-asserted-by":"crossref","unstructured":"Russell, P., Eley, S. M., Ellis, J. et al. (2000). Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. Journal of Antimicrobial Chemotherapy45, 813\u20138.","DOI":"10.1093\/jac\/45.6.813"},{"key":"key\n\t\t\t\t20171013015248_R11","doi-asserted-by":"crossref","unstructured":"Chetchotisakd, P., Chaowagul, W., Mootsikapun, P. et al. (2001). Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline. American Journal of Tropical Medicine and Hygiene64, 24\u20137.","DOI":"10.4269\/ajtmh.2001.64.24"},{"key":"key\n\t\t\t\t20171013015248_R12","doi-asserted-by":"crossref","unstructured":"Moore, R. A., DeShazer, D., Reckseidler, S. et al. (1999). Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrobial Agents and Chemotherapy43, 465\u201370.","DOI":"10.1128\/AAC.43.3.465"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/54\/6\/1134\/2542765\/dkh471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T17:10:23Z","timestamp":1541437823000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/54\/6\/1134\/856093\/Antibiotic-susceptibility-of-65-isolates-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,12]]},"published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh471","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,12]]},"published":{"date-parts":[[2004,12,1]]}}}